Our Mission is Clear

Our mission is to provide rheumatologists with deeper clinical insights and help enable more effective management of patients with autoimmune and inflammatory diseases. Our goal is to create a broad portfolio of specialty diagnostic tests that will enable more effective patient management and improve patient outcomes.

Crescendo Bioscience is working with physicians, clinical researchers, healthcare administrators, and others to develop an overall strategy that offers:
  • Valuable information on individual disease biology to enable rheumatologists and their patients to manage disease
  • Comprehensive test reports to facilitate patient management based on a full assessment of both biology and clinical disease manifestations, and allow longitudinal tracking of chronic disease
  • An ability to collect meaningful information on individual treatment decisions and outcomes to inform the next generation of therapeutics


Federal CLIA Certificate

The Centers for Medicare & Medicaid Services (CMS) regulate all laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The objective of the CLIA program is to ensure quality laboratory testing. www.cms.gov

New York State Clinical Laboratory Permit

The Wadsworth Center at the New York Department of Health through its Clinical Laboratory Evaluation Program (CLEP) issued a laboratory permit to Crescendo Bioscience to provide services to physicians/patients in New York. The excellence of the CLEP program has been acknowledged by CMS through their granting of exempt status from the federal CLIA for laboratories located in and holding NYS clinical laboratory permits.

CMS coverage policy issued by Palmetto GBA for Vectra DA

Palmetto GBA posted a favorable coverage article for Vectra DA on May 10, 2013 under the Medicare Part B program, which also drives coverage policies for the large Medicare Advantage Plans.

CAP Laboratory Accreditation Program

The commission on Laboratory Accreditation of the College of American Pathologists (www.cap.org) examined Crescendo Bioscience’s laboratory records and quality control procedures for the preceding 2 years. In addition, staff qualifications, laboratory equipment, and the facility’s safety program and record, as well as the overall lab management were examined.

©2019 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, MyRA and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc. in the United States and other jurisdictions.